Skip to content

Clinical trials

Phase 4 Cardiovascular Diseases trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 4 Country / region: Brazil Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20071
20092
20111
20121
20142
20191
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status4
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Sao Paulo3
Amgen1
Boehringer Ingelheim1
Federal University of Pelotas1
Hospital de Clinicas de Porto Alegre1
Instituto Dante Pazzanese de Cardiologia1
Instituto de Cardiologia do Rio Grande do Sul1
Novartis1
Pfizer1
Science Valley Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases13
Atherosclerosis3
Hypertension3
Chronic Limb-Threatening Ischemia2
Peripheral Arterial Disease2
Sleep Apnea, Obstructive2
Stroke2
Acute Coronary Syndrome1
Arrhythmias, Cardiac1
Arterial Occlusive Diseases1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.